Zopiclone is a powerful sleep aid that works by enhancing the effects of the brain’s GABA (gamma-aminobutyric acid) neurotransmitter system, which inhibits brain activity and induces relaxation. By doing this, it helps people fall asleep more easily and stay asleep longer, helping them feel well rested and refreshed when they wake up. Unfortunately, many individuals who use this drug for extended periods of time develop a tolerance to it, which can lead them to start increasing the dosage in order to achieve the same sleep-inducing results. This escalation in dosage is a strong indicator of addiction, which makes it vital to only use this medication under the care of a physician.

In this study, researchers analyzed a randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial of short-term zopiclone treatment for insomnia in advanced cancer patients. The trial included patients with metastatic malignant disease and reported insomnia who were enrolled in a palliative care clinic. Patients were randomized to receive zopiclone or placebo for six subsequent nights. The primary end point was patient-reported sleep quality on the final study night. Secondary end points included sleep onset latency and total sleep time (TST).

The authors concluded that zopiclone significantly improved short-term patient-reported sleep quality during the course of the trial, which was adjusted for baseline sleep quality. However, these results cannot be generalized to other patient populations, and further investigation of the impact of zopiclone in the context of other chronic diseases is needed. Furthermore, a better understanding of the factors associated with the development and persistence of insomnia in palliative care patients is also warranted.

As a sleeping pill, Zopiclone tablets may help you fall asleep faster and stay asleep longer, but it doesn’t address the underlying cause of your insomnia and won’t be effective long-term. The best option for treating insomnia is cognitive behavioural therapy for insomnia (CBTi). At Sleepstation, we offer an evidence-based CBTi programme that is proven to improve sleep and produces sustainable results.

Zopiclone is in a class of medicines called sedatives and hypnotics. It can cause side effects like drowsiness, dizziness, and confusion. It can also reduce your reaction times and increase the risk of accidents or falls, especially if you are elderly or have certain health problems.

Contact Us:- [email protected] | +15056725168